Open AccessEvaluation of Gonorrhea Test of Cure at 1 Week in a Los Angeles Community-Based Clinic Serving Men Who Have Sex With Men
Author(s) -
Matthew R Beymer,
Eloisa Llata,
Ali Stirland,
Hillard Weinstock,
Christine L. Wigen,
Sarah Guerry,
Everardo Mejia,
Robert Bolan
Publication year - 2014
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000000190
Subject(s) - medicine , gonorrhea , men who have sex with men , logistic regression , neisseria gonorrhoeae , sexually transmitted disease , demography , neisseria , syphilis , family medicine , genetics , human immunodeficiency virus (hiv) , sociology , bacteria , microbiology and biotechnology , biology
Because of the decreasing susceptibility of Neisseria gonorrhoeae to cephalosporin therapy, the Centers for Disease Control and Prevention recommends test of cure (TOC) 1 week after gonorrhea (GC) treatment if therapies other than ceftriaxone are used. In addition, the Centers for Disease Control and Prevention asks clinicians, particularly those caring for men who have sex with men (MSM) on the west coast, to consider retesting all MSM at 1 week. However, it is unclear if this is acceptable to providers and patients or if nucleic acid amplification tests (NAATs) are useful for TOC at 7 days.